Implementation of device therapy (cardiac resynchronization therapy and implantable cardioverter defibrillator) for patients with heart failure in Europe: changes from 2004 to 2008.
about
2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of theComparing outcome of patients with coronary artery disease and dilated cardiomyopathy in ICD and CRT recipients: data from the German DEVICE-registry.Current use of implantable electrical devices in Sweden: data from the Swedish pacemaker and implantable cardioverter-defibrillator registry.[Inappropriate ICD therapies: All problems solved with MADIT-RIT?].Reduction of inappropriate anti-tachycardia pacing therapies and shocks by a novel suite of detection algorithms in heart failure patients with cardiac resynchronization therapy defibrillators: a historical comparison of a prospective database.Effectiveness of cardiac resynchronization therapy in mild congestive heart failure: systematic review and meta-analysis of randomized trials.Laser lead extraction to facilitate cardiac implantable electronic device upgrade and revision in the presence of central venous obstruction.Five-year survival of patients with chronic systolic heart failure of ischemic and non-ischemic etiology: analysis of prognostic factors.Fluid status monitoring with a wireless network to reduce cardiovascular-related hospitalizations and mortality in heart failure: rationale and design of the OptiLink HF Study (Optimization of Heart Failure Management using OptiVol Fluid Status MoniChanging nature of cardiac interventions in older adultsPotential value of automated daily screening of cardiac resynchronization therapy defibrillator diagnostics for prediction of major cardiovascular events: results from Home-CARE (Home Monitoring in Cardiac Resynchronization Therapy) study.Remote monitoring and follow-up of cardiovascular implantable electronic devices in the Netherlands : An expert consensus report of the Netherlands Society of CardiologyClinical implementation of cardiac resynchronization therapy-regional disparities across selected ESC member countriesA survey of cardiac implantable electronic device implantation in India: By Indian Society of Electrocardiology and Indian Heart Rhythm Society.Complex cardiac pacing in the setting of a district general hospital: procedural success and complications.Clinical trials update from the European Society of Cardiology Meeting 2011: ARISTOTLE, SMART-AV: QLV substudy, SHIFT: echocardiography and quality of life substudies, European CRT Survey, and Basic Science Update.Meta-analysis of randomized controlled trials evaluating left ventricular vs. biventricular pacing in heart failure: effect on all-cause mortality and hospitalizations.Heart failure highlights in 2011.Long-term impact of cardiac resynchronization therapy in mild heart failure: 5-year results from the REsynchronization reVErses Remodeling in Systolic left vEntricular dysfunction (REVERSE) study.Preventing ventricular dysfunction in pacemaker patients without advanced heart failure: results from a multicentre international randomized trial (PREVENT-HF).Mobile thrombus on cardiac implantable electronic device leads of patients undergoing cardiac ablation: incidence, management, and outcomes.Prognostic Estimation of Advanced Heart Failure With Low Left Ventricular Ejection Fraction and Wide QRS Interval.Phantom shocks: innocent bystander or complication of implantable cardioverter defibrillator therapy?Cardiac resynchronization in mild heart failure: all issues resolved? Editorial to "Cardiac resynchronization therapy in patients with mild heart failure: a systematic review and meta-analysis of randomized controlled trials" by Ronghui Tu et al.Clinical trials update from the American College of Cardiology meeting 2010: DOSE, ASPIRE, CONNECT, STICH, STOP-AF, CABANA, RACE II, EVEREST II, ACCORD, and NAVIGATOR.Clinical trials update from the American College of Cardiology Meeting 2011: STICH, NorthStar, TARGET, and EVEREST II.Close connection between improvement in left ventricular function by cardiac resynchronization therapy and the incidence of arrhythmias in cardiac resynchronization therapy-defibrillator patients.Age, prognostic impact of QRS prolongation and left bundle branch block, and utilization of cardiac resynchronization therapy: findings from 14,713 patients in the Swedish Heart Failure Registry.Incidence and clinical relevance of uncontrolled ventricular rate during atrial fibrillation in heart failure patients treated with cardiac resynchronization therapy.Clinical trials update from the American Heart Association meeting 2010: EMPHASIS-HF, RAFT, TIM-HF, Tele-HF, ASCEND-HF, ROCKET-AF, and PROTECT.Effect of a telemonitoring-facilitated collaboration between general practitioner and heart failure clinic on mortality and rehospitalization rates in severe heart failure: the TEMA-HF 1 (TElemonitoring in the MAnagement of Heart Failure) study.The European CRT Survey: 1 year (9-15 months) follow-up results.3D cardiovascular navigation system: accuracy and reduction in radiation exposure in left ventricular lead implant.EURObservational Research Programme: the Heart Failure Pilot Survey (ESC-HF Pilot).Long-term incidence of inappropriate shocks in patients with implantable cardioverter defibrillators in clinical practice-an underestimated complication?Biventricular pacing in pacemaker dependency: one size does not fit all.Utilization and in-hospital complications of cardiac resynchronization therapy: trends in the United States from 2003 to 2013.Prevalence of potential cardiac resynchronization therapy candidates and actual use of cardiac resynchronization therapy in patients hospitalized for heart failure.The effect of cardiac resynchronization therapy on left ventricular diastolic function assessed with speckle-tracking echocardiography.Redistribution of left ventricular strain by cardiac resynchronization therapy in heart failure patients.
P2860
Q28087002-F43E83B9-57F8-4642-B613-0C07968C6D37Q30609810-FD4870C1-B8C1-4CEC-BA15-7B1336019113Q30863604-226201C2-FA9F-4D9F-B8F7-3EE928CEE157Q33165644-AFE45358-B381-4785-BD72-6F54AF508930Q33166757-526FF374-07A3-4A58-B9BE-68D4DF8D353AQ33750390-EA5DE737-592C-4776-BAC7-6F1789D69EFDQ34781829-41E66F0B-90E3-48A2-8F54-AAD9030DAF83Q34821843-1A216B59-D090-4957-A9D1-9782F561ACAAQ35073703-380DD91E-01B9-444A-9CBD-DCE191376063Q35086463-544DACD8-9CD1-451A-8B58-4426F995EC1BQ35170240-AEAC0F89-F4C6-44CD-85A9-150740A041B5Q35693546-4761A08C-6FFA-4AFA-9079-26EC64F0FB2DQ36302541-05959FB7-2F1D-450B-86D0-B955068A4574Q36595306-4A738129-9B01-4685-92BA-EE342C20B162Q36800887-6D3956C1-0357-428C-B85F-0BE0C6B37671Q37958845-AA712B2D-8A02-4E1E-B0FE-FB0AC311985AQ38003238-78A71F55-02A7-4084-AD0E-53571196D6E5Q38035177-9CC014A9-FBF4-4B4F-9397-5B36AAB13D7EQ38452103-4AC01523-5C89-4CE3-A2E5-CC6F83ABA926Q38490528-7027E998-15F2-4B4D-994D-695528B07019Q40228929-23755954-1C2B-4E84-A7CE-4DD72D76E667Q41317940-18598B15-1184-4401-8237-9C332BBCCC68Q41579930-D2791380-7AC0-46B5-ADEA-6B5B7BDD9788Q42857492-29D060FE-FD9A-4204-8CF6-FEAB12189051Q43055364-E74A0B5C-2B68-47F5-9843-DC9F2BCDE280Q43889171-D033F82C-7157-482C-A3A7-5486E34B00F5Q43956436-13153778-D9EC-4FB1-A5E4-B2816E12EA07Q43998937-D6268E54-5865-4011-A387-72F7BBD0B6AEQ44358685-71F8B8F8-4E3B-40D0-94D9-5C89CC561CB3Q44825076-C3C58CAA-F59F-480E-8B29-DE9D2C5AED43Q45382854-43D4922A-1388-4460-8D80-2C99EAC5EC73Q46029893-8B0822E2-D58B-4D29-9C1F-75C35A51EC14Q46055695-5AF33161-CD4A-4150-8EB3-8BDCE8D4C18DQ46414626-1195DC68-4C2F-4B5C-B8D0-15CDE5BE83EAQ47311969-992C8800-5AE9-4CD1-B615-985D54C22DCAQ47374950-F650B983-DE30-4D26-95E3-62FD0C8FCE9CQ47820098-C7DF0212-B7E6-44D1-97E3-0C4BC360A653Q49170764-DFEB1C6C-FB97-4D0D-8CEF-73CA5DC21EB1Q50673814-7EF36430-746E-4AE3-9B70-78427A20DA91Q50691824-85059B72-8405-4577-B6D5-6CBEEDF015A0
P2860
Implementation of device therapy (cardiac resynchronization therapy and implantable cardioverter defibrillator) for patients with heart failure in Europe: changes from 2004 to 2008.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Implementation of device thera ...... pe: changes from 2004 to 2008.
@en
Implementation of device therapy
@nl
type
label
Implementation of device thera ...... pe: changes from 2004 to 2008.
@en
Implementation of device therapy
@nl
prefLabel
Implementation of device thera ...... pe: changes from 2004 to 2008.
@en
Implementation of device therapy
@nl
P2093
P2860
P50
P356
P1476
Implementation of device thera ...... pe: changes from 2004 to 2008.
@en
P2093
Alexander H Maass
Isabelle C van Gelder
Pelle Stolt
Silvia G Priori
P2860
P304
P356
10.1093/EURJHF/HFP149
P577
2009-11-01T00:00:00Z